BriaCell Summarizes Clinical Data Poster Presented at the 2021 San Antonio Breast Cancer Symposium®GlobeNewsWire • 12/09/21
BriaCell Adds Mary Crowley Cancer Research Center as a Clinical Trial Site for its Phase I/IIa Breast Cancer StudyGlobeNewsWire • 11/18/21
BriaCell Announces Update on Previously Announced Securities Buyback Program and Participation at Upcoming ConferencesGlobeNewsWire • 11/12/21
5 Short Squeeze Candidates To Watch: Progenity Tops List Again, Cassava Sciences Joins Following Short ReportBenzinga • 11/08/21
BriaCell Adds Pioneering Immunologist and Cancer Immunotherapy Expert, Suzanne Ostrand-Rosenberg, Ph.D., to its Scientific Advisory BoardGlobeNewsWire • 11/05/21
BriaCell Appoints Renowned Pharmaceutical Veteran Jane Gross, Ph.D. to its Board of DirectorsGlobeNewsWire • 11/02/21
BriaCell's Survival Story Could Mean a Better Chance of Survival for Women Suffering from Breast CancerBenzinga • 09/23/21
BriaCell Announces Securities Buyback to Purchase up to 10% of Common Shares and up to 10% of Listed WarrantsGlobeNewsWire • 09/09/21
BriaCell and ImaginAb Announce Collaboration to Evaluate Immunotherapy Imaging Technology in Advanced Breast CancerGlobeNewsWire • 08/19/21
BriaCell's Early-Stage Combination Study In Advanced Breast Cancer Starts EnrollmentBenzinga • 07/14/21
BriaCell Phase I/IIa Clinical Trial Combination Study in Advanced Breast Cancer Patients Open for EnrollmentGlobeNewsWire • 07/14/21
BriaCell Extends Personalized Breast Cancer Immunotherapy To Prostate & Lung Cancer And MelanomaBenzinga • 06/16/21
BriaCell Therapeutics Expands Breast Cancer Platform Technology into Prostate, Melanoma, and Lung CancersGlobeNewsWire • 06/16/21
BriaCell Therapeutics Announces Proceeds of US$12.88 Million from Warrant ExercisesGlobeNewsWire • 06/10/21
BriaCell to Host Corporate and Clinical Update Conference Call Wednesday, June 16, 2021 at 4:30 p.m. ETGlobeNewsWire • 06/09/21
BriaCell Therapeutics Corp. Announces Closing of US$27.2 Million Private PlacementGlobeNewsWire • 06/07/21
BriaCell stock more than doubles on heavy volume after upbeat update on breast cancer treatmentMarket Watch • 06/02/21
BriaCell Stock Doubles After Reporting Overall Survival Benefit in Pretreated Breast Cancer PatientsBenzinga • 06/02/21